Features
Photodynamic Therapy for Polypoidal or Subretinal Aneurysmal Neovascularization
Combination treatment with PDT could provide better results than anti-VEGF monotherapy.
By Gregg T. Kokame, MD, MMM, Jase N. Omizo, BS, Kelli A. Kokame, BA
Targeting Innate Immune Activity in Age-Related Macular Degeneration
Promising candidate molecules are in later stages of development.
By Carl D. Regillo, MD, FACS, Jeffrey S. Heier, MD
The Latest on Drug Delivery in the Suprachoroidal Space
Maximize treatment effect and minimize exposure to other ocular tissues.
By Mark R. Barakat, MD
Web Exclusives
The Effect of the COVID-19 Pandemic on Retina Clinical Trials
Some critical safety changes might streamline future trials.
By Margaret Chang, MD
Departments
Retinal OCT Biomarkers for Clinicians and Clinical Researchers
Recent studies may yield meaningful prognostic and treatment guidance.
By Michael Gemayel, MD, Thomas A. Ciulla, MD, MBA
Characteristics of Patients Started on Brolucizumab
A large registry study demonstrates that patients on the newer drug had better baseline vision.
By Mathew W. MacCumber, MD, PhD
UPFRONT: How Categorizing Retinal Disease Affects Treatment Patterns
By Peter K. Kaiser, MD
CLINICAL TRIAL DOWNLOAD: Phase 1b Results for an Anti-VEGF Antibody Biopolymer Conjugate
This drug could offer a new option for extended dosing.
By Yasha Modi, MD , Diana V. Do, MD, Anthony Joseph, MD, et al.
CODING Q&A: Medical Record Signature Options
Medicare offers multiple ways to meet the requirement.
By Suzanne L. Corcoran, COE
NEW PRODUCT APPLICATIONS: Retinal Imager Can Track Blood Flow Without Dye
Data can be used to establish diagnoses, prognosis, and response to treatment.
By Karen Appold, contributing writer
News
SUBSPECIALTY NEWS: Ophthalmic bevacizumab, add-on AMD therapy, gene therapy, and more.
By Jerry Helzner, contributing editor
Supplements
Anti-VEGF Therapy & AMD
A LOOK AT CURRENT AVAILABILITY AND OPPORTUNITIES TO CHANGE TREATMENTS
By Priya Vakharia, MD
The Importance of Imaging in Diagnosis
OPTIMIZING OCT TECHNOLOGY FOR NEOVASCULAR AMD TREATMENT
By Yasha Modi, MD , Saagar A. Pandit, MD, MPH